Damon Runyon’s Board of Directors

CHAIRMAN
Mr. Alan M. Leventhal
Chairman and CEO
Beacon Capital Partners, LLC
Boston, Massachusetts

VICE CHAIRMAN, SCIENTIFIC PROGRAMS
David M. Livingston, MD
Deputy Director
Dana-Farber/Harvard Cancer Center
Emil Frei III Professor
Harvard Medical School
Boston, Massachusetts

VICE CHAIRMAN, FINANCE AND TREASURER
Mr. Leon G. Cooperman
Chairman and CEO
Omega Advisors, Inc.
New York, New York

VICE CHAIRMAN, AUDIT AND CORPORATE GOVERNANCE
Sanford W. Morhouse, Esq.
Of Counsel
Dewey & Leboeuf LLP
New York, New York

VICE CHAIRMAN, BOARD DEVELOPMENT
Mr. Michael L. Gordon
Chief Operating Officer
Angelo, Gordon & Company LP
New York, New York

VICE CHAIRMAN, DEVELOPMENT AND COMMUNICATIONS
Mr. David M. Beirne
Aspen, Colorado

Steven J. Burakoff, MD
Director, The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, New York

William L. Carroll, MD
Director
NYU Cancer Institute
New York, New York

Mr. Gary E. Erlbaum
President
Greentree Properties
Ardmore, Pennsylvania

Thomas J. Fahey, Jr., MD
Senior Vice President Emeritus
Memorial Sloan-Kettering Cancer Center
New York, New York

Mr. Buck French
Darien, Connecticut

Mr. Dale F. Frey
Retired Chairman of the Board and President
General Electric Investment Corporation
Stamford, Connecticut

Mr. John A. Fry
President
Drexel University
Philadelphia, Pennsylvania

Elaine V. Fuchs, PhD
Rebecca C. Lancefield Professor
Investigator, Howard Hughes Medical Insitute
Head, Laboratory of Mammalian Cell Biology and Development
The Rockefeller University
New York, New York

Richard B. Gaynor, MD
Vice President
Cancer Research and Clinical Investigation
Eli Lilly and Company
Indianapolis, Indiana

Todd R. Golub, MD
Director, Cancer Program
The Broad Institute of MIT and Harvard
Cambridge, Massachusetts

Mr. Scott Greenstein
President
Entertainment and Sports
Sirius Satellite Radio
New York, New York

Mr. Steve Hayden
Vice Chairman
Ogilvy & Mather Worldwide
New York, New York

Mr. William W. Helman
CEO & Managing Partner
Greylock Partners
Cambridge, Massachusetts

Mr. Jay W. Ireland
President and CEO
GE Africa
Nairobi, Kenya

Mr. Steven A. Kandarian
President and CEO
MetLife
New York, New York

Mr. Noah Knauf
Principal
Warburg Pincus
San Francisco, California

Ronald Levy, MD
Chief, Division of Oncology
Professor of Medicine
Stanford University School of Medicine
Stanford, California

Mr. David G. Marshall
Chairman and CEO
Amerimar Realty Company
Philadelphia, Pennsylvania

Mr. John H. Myers
Senior Advisor
Angelo, Gordon & Company LP
New York, New York

Richard J. O’Reilly, MD
Chair, Department of Pediatrics
Chief, Pediatric Bone Marrow Transplant Service
Claire L. Tow Chair in Pediatric Oncology Research
Memorial Sloan-Kettering Cancer Center
New York, New York

Mr. Andrew S. Rachleff
President and CEO
Wealthfront
Faculty, Stanford Graduate School of Business
Palo Alto, California

Mr. Scott Ryles
Chief Executive Officer and President
Home Value Insurance Company
San Francisco, California

Ms. Karen D. Seitz
Founder and Managing Director
Fusion Partners
New York, New York

William R. Sellers, MD
Vice President & Global Head, Oncology
Novartis Institutes for BioMedical Research
Cambridge, Massachusetts

Samuel C. Silverstein, MD
John C. Dalton Professor
Department of Physiology and Cellular Biophysics
Columbia University
New York, New York

Letter from the President and CEO

December 2011

Thank you for supporting Damon Runyon in 2011. Our work would not have been possible without you!

As illustrated in this year’s Annual Report poster and booklet, we have reached a critical point in our fight against cancer. The important discoveries of the past decade have led us to a new era in which breakthroughs in the diagnosis, treatment and prevention of cancer are being made more rapidly.

Damon Runyon is at the forefront of this revolution. With your support, we continue to fund young scientists uniquely capable of capitalizing on this progress and pushing for new breakthroughs.

We need your help to keep these brilliant minds in the lab fighting cancer. Please give what you can today.

Thank you, and best wishes for the holiday season,

Lorraine W. Egan
President and CEO

p.s.  As always, 100% of your gift will go to the nation’s top young researchers, because our administrative costs are paid through Damon Runyon Broadway Tickets and our endowment. 

Staff of the Damon Runyon Cancer Research Foundation

Lorraine W. Egan
President and Chief Executive Officer
212.455.0541 • lorraine.egan@damonrunyon.org

ALLIANCES & PARTNERSHIPS
Andrea (Andi) H. Ciminello
Director of Alliance Development
212.455.0504 • andrea.ciminello@damonrunyon.org

AWARD PROGRAMS
Clare M. Cahill
Chief Administrative Officer
212.455.0522 • clare.cahill@damonrunyon.org

Yung S. Lie, PhD
Chief Scientific Officer
212.455.0521 • yung.lie@damonrunyon.org

Cait Ahearn
Programs Associate
212.455.0523 • cait.ahearn@damonrunyon.org

Katie Greis
Programs Assistant
212.455.0524 • katie.greis@damonrunyon.org

COMMUNICATIONS
Todd Brogan
Communications Coordinator
212.455.0552 • todd.brogan@damonrunyon.org

DAMON RUNYON BROADWAY TICKETS
Marialice C. Pagnotta
Director of the Damon Runyon Broadway Tickets Service
212.455.0550 • marialice.pagnotta@damonrunyon.org

DEVELOPMENT
Elizabeth Portland
Director of Development
212.455.0508 • elizabeth.portland@damonrunyon.org

Toby Falk
Development Administrator
212.455.0502 • toby.falk@damonrunyon.org

Kristen Dempsey
Development Coordinator
212.455.0505 • kristen.dempsey@damonrunyon.org

Tegan Aherne
Development Assistant/Receptionist
212.455.0534 • tegan.aherne@damonrunyon.org

EVENTS
Kimberly Kubert
Director of Special Events
212.455.0501 • kimberly.kubert@damonrunyon.org

Liz Benham
Special Events Coordinator
212.455.0503 • liz.benham@damonrunyon.org

FINANCE
Travis Carey
Chief Financial Officer
212.455.0531 • travis.carey@damonrunyon.org

Corey Sandman
Senior Accountant / Information System Coordinator
212.455.0532 • corey.sandman@damonrunyon.org

Lillian Sun
Junior Accountant / Accounts Payable
212.455.0533 • lillian.sun@damonrunyon.org